Prenatal testing

United States Non-Invasive Prenatal Testing Market Report 2020: Growth, Demand, Trends, Opportunity, Forecasts - Market is Anticipated to Surpass US$ 2.2 Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 8, 2020
Health, Other Health, Branches of biology, Clinical medicine, Midwifery, Medicine, NIPT, Prenatal testing, Down syndrome, Prenatal development, Natera, Sequenom

The "U.S. Non-Invasive Prenatal Testing Market - Growth, Demand, Trends, Opportunity, Forecasts (2020 - 2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "U.S. Non-Invasive Prenatal Testing Market - Growth, Demand, Trends, Opportunity, Forecasts (2020 - 2027)" report has been added to ResearchAndMarkets.com's offering.
  • The United States Non-Invasive Prenatal Testing market is anticipated to grow over US$ 2.2 Billion by 2027.
  • The growth in the U.S. Non-Invasive Prenatal Testing (NIPT) market is largely attributed to factors such as the high risk of chromosomal abnormalities with increasing maternal age, increase in incidences of chromosomal aneuploidies among fetus, development of advanced non-invasive prenatal testing products, rising awareness regarding non-invasive prenatal testing, rising focus on reimbursement for NIPT, increasing preference for non-invasive techniques over invasive methods and ACOG guidelines recommend NIPT for all pregnancies regardless of risk.
  • Key Features of the Study:
    A Comprehensive List of the Key Players Along with the Analysis of their Current NIPT Test Portfolios, Business Overview, and Recent Development
    The Key Market Players for the United States Non-Invasive Prenatal Testing Market Are Listed Below:

Cradle Genomics Expands Executive Team, Accelerating Efforts to Transform Non-Invasive Prenatal Testing and Patient Care

Retrieved on: 
Friday, July 24, 2020
Branches of biology, Midwifery, Prenatal testing, Genomics, Medical genetics

"Our mission at Cradle is to deliver genetic knowledge for life, with a vision of better outcomes for every pregnancy," saidTristan Orpin, CEO of Cradle Genomics.

Key Points: 
  • "Our mission at Cradle is to deliver genetic knowledge for life, with a vision of better outcomes for every pregnancy," saidTristan Orpin, CEO of Cradle Genomics.
  • Gross as CMO will enable Cradle to achieve our vision of transforming prenatal testing and patient care."
  • She is widely published in peer-reviewed journals and has both led and participated in a number of research studies in consumer and clinical genomics.
  • Cradle Genomics is headquartered inSan Diego, California.Cradle is developing novel fetal genetic analysis and pregnancy health solutions at the earliest stages of pregnancy.

Illumina’s Noninvasive Prenatal Screening Kit Receives Regulatory Approval in S. Korea

Retrieved on: 
Tuesday, June 23, 2020
Biotechnology, Health, Consumer, Other Health, Research, Public relations, Investor relations, Medical devices, General Health, Baby, Maternity, Communications, Genetics, Science, Women, Clinical trials, Branches of biology, Natural sciences, Biology, Biotechnology, Molecular biology, Laboratory techniques, Polymerase chain reaction, Midwifery, Prenatal testing, NIPT, Sequenom, Natera

Now with MFDS accrediting Illuminas NIPT solution providing extended genetic information of fetus, we are excited to have a regulatory approved NIPT test.

Key Points: 
  • Now with MFDS accrediting Illuminas NIPT solution providing extended genetic information of fetus, we are excited to have a regulatory approved NIPT test.
  • Performance of a genome-wide PCR-free, paired-end sequencing-based noninvasive prenatal screening test, VeriSeq NIPT Solution v2, in the detection of fetal chromosomal anomalies.
  • Validation of VeriSeq NIPT Solution v2, a paired-end PCR-free WGS-based methodology for noninvasive prenatal screening of fetal aneuploidies and CNVs on a genome-wide scale.
  • OC02.02 Performance of a genome-wide PCR-free, paired-end sequencing-based noninvasive prenatal screening test, VeriSeq NIPT Solution v2.

Global Non-Invasive Prenatal Testing Market Assessment 2020-2025 - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 18, 2020
Medical Supplies, Health, Midwifery, Prenatal testing, Branches of biology, Health care, Health, Natera, Sequenom

The "Global Non-Invasive Prenatal Testing Market Assessment 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Non-Invasive Prenatal Testing Market Assessment 2020-2025" report has been added to ResearchAndMarkets.com's offering.
  • Major factors driving the growth of the non-invasive prenatal testing market globally are rising prevalence of genetic disorders, quick adoption on next-generation sequencing, new product launches, and an upsurge in several non-invasive prenatal testing service providers.
  • Additionally, advantages of non-invasive prenatal tests over other prenatal tests such as non-invasive nature, better accuracy, and short duration of the procedure are anticipated to hasten the growth of the global non-invasive prenatal testing market during the forecast period.
  • Non-Invasive Prenatal Testing market is very competitive with most of the players competing to maximize market shares.

PerkinElmer Launches Pre-eclampsia Kit for Enhanced Management

Retrieved on: 
Wednesday, June 10, 2020
Women, Biotechnology, Pharmaceutical, Health, Medical devices, Baby, Maternity, Genetics, Consumer, Medical emergencies, RTT, Medicine, Clinical medicine, Health, Pre-eclampsia, Women's health, Midwifery, Soluble fms-like tyrosine kinase-1, Eclampsia, Prenatal testing, PerkinElmer

PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, announced today the addition of the DELFIA Xpress sFlt-1 kit to its CE-IVD pre-eclampsia product offerings.

Key Points: 
  • PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, announced today the addition of the DELFIA Xpress sFlt-1 kit to its CE-IVD pre-eclampsia product offerings.
  • For risk assessment and diagnosis of pre-eclampsia, accurate results enable health care to primarily predict and prevent pre-eclampsia and also to provide improved management for all women, said Petra Furu, GM, Reproductive Health, PerkinElmer.
  • PerkinElmers prenatal screening assays and testing solutions are clinically validated and are ideal for all modern prenatal management strategies.
  • PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare.

Non-Invasive Prenatal Testing (NIPT) Market Assessment 2015-2025: Implications of the COVID-19 Crisis

Retrieved on: 
Wednesday, May 27, 2020
NIPT, Prenatal testing, Genetic disorder, Natera, Health care

The Global Non-Invasive Prenatal Testing (NIPT) Market is expected to witness a robust growth during the forecast period.

Key Points: 
  • The Global Non-Invasive Prenatal Testing (NIPT) Market is expected to witness a robust growth during the forecast period.
  • Increasing genetic disorders in pre-borne children and growing population are the major factors for the growth of the market.
  • However, high maintenance and lack of competent professionals are major factors restraining the growth of the market across the globe.
  • The Global Non-Invasive Prenatal Testing (NIPT) Market is segmented based on application, product, technology, end-user and region.

Global Non-invasive Prenatal Testing (NIPT) Market, Forecast to 2025 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 26, 2020
Branches of biology, Genetics, Chromosomal abnormalities, Syndromes, Syndromes affecting the heart, Cytogenetics, NIPT, Prenatal testing, Patau syndrome, Down syndrome, Patau, Trisomy

The "Global Non-invasive Prenatal Testing (NIPT) Market By Application (Trisomy (Down syndrome, Edwards syndrome, Patau syndrome), Turner syndrome, Rh Blood type and Others), By Product, By Technology, By End User, By Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Non-invasive Prenatal Testing (NIPT) Market By Application (Trisomy (Down syndrome, Edwards syndrome, Patau syndrome), Turner syndrome, Rh Blood type and Others), By Product, By Technology, By End User, By Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.
  • The Global Non-Invasive Prenatal Testing (NIPT) Market is expected to witness a robust growth during the forecast period.
  • Increasing genetic disorders in pre-borne children and growing population are the major factors for the growth of the market.
  • The Global Non-Invasive Prenatal Testing (NIPT) Market is segmented based on application, product, technology, end-user and region.

Novagen Is Proud to Offer Top DNA Testing Services for The People of Vietnam

Retrieved on: 
Tuesday, May 26, 2020
Branches of biology, Medicine, Clinical medicine, DNA, Medical genetics, Medical tests, Biotechnology, Midwifery, Prenatal testing, Genetic testing, Cell-free fetal DNA, Elective genetic and genomic testing

DNA testing is the process of verifying a blood relationship between two people by comparing specific DNA markers in each person's genome.

Key Points: 
  • DNA testing is the process of verifying a blood relationship between two people by comparing specific DNA markers in each person's genome.
  • Novagen is offering DNA testing services that focus on gene identification services, DNA testing, prenatal DNA testing, genetic testing and NIPT noninvasive prenatal screening.
  • The Novagen testing laboratory is meeting the ISO 9001: 2015 standard and is the first company to apply 27 loci testing technology in DNA testing.
  • Customers of Novagen can access various types of testing and services such as DNA tests for father and son, DNA test for the birth certificate, DNA tests for illegitimate son, prenatal DNA test, non-invasive fetal DNA test , DNA tests for mother and children, DNA testing for Bowel DNA, DNA tests for grandparents and grandchildren, DNA tests for relatives, screening for non-invasive birth defects, sequencing of new generation NGS gene.

2020 Study on the Genetic Testing Industry - Featuring Profiles of Abbott Labs, Roche Diagnostics, Myriad Genetics, Thermo Fisher Scientific, Hologic, Cepheid, Agilent Technologies, QIAGEN, and More

Retrieved on: 
Friday, April 3, 2020
Branches of biology, Medicine, Clinical medicine, Medical genetics, Medical tests, Alternatives to animal testing, Genetic testing, Biotechnology, Prenatal testing, Newborn screening, Elective genetic and genomic testing, Predictive medicine

Growing awareness about genetic testing, technological advances in genetic sequencing, and rising incidences of genetic diseases especially cancer are some of the major factors propelling the genetic testing market.

Key Points: 
  • Growing awareness about genetic testing, technological advances in genetic sequencing, and rising incidences of genetic diseases especially cancer are some of the major factors propelling the genetic testing market.
  • Global Genetic Testing Market Outlook 2022 provides a detailed analysis of the genetic testing market.
  • The segmentation of genetic testing markets has been done in the report on the basis of applications, diseases, and geographical regions.
  • 1) Based on the application, the genetic testing market is divided into Diagnostic Testing, Newborn Screening, Prenatal Testing, Carrier Screening, and Others.

Global Genetic Testing Market Outlook to 2022 by Application, Disease & Geography - ResearchAndMarkets.com

Retrieved on: 
Friday, April 3, 2020
Health, Genetics, Branches of biology, Medicine, Clinical medicine, Medical genetics, Medical tests, Alternatives to animal testing, Genetic testing, Biotechnology, Prenatal testing, Elective genetic and genomic testing, Predictive medicine

The "Global Genetic Testing Market Outlook 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Genetic Testing Market Outlook 2022" report has been added to ResearchAndMarkets.com's offering.
  • Growing awareness about genetic testing, technological advances in genetic sequencing, and rising incidences of genetic diseases especially cancer are some of the major factors propelling the genetic testing market.
  • Global Genetic Testing Market Outlook 2022 provides a detailed analysis of the genetic testing market.
  • 1) Based on the application, the genetic testing market is divided into Diagnostic Testing, Newborn Screening, Prenatal Testing, Carrier Screening, and Others.